Pros
People are nice and they have 1 great product, Dotarem.
Cons
The actual headquarters is in France and they do not know how to run a US pharmaceutical company. They ended up laying off ~1,000 who came from the Liebel-Flarsheim (LF)business they bought ~5 years prior. The entire St. Louis team who was the backbone for LF (Administrative Operations i.e. Finance, Contracts, Pricing, Legal, AP, AR, Customer Service, Chargebacks, IT, Procurement, etc.) was let go or their positions were replaced and moved elsewhere. They moved North America finance to Mexico. The rest of the positions are scattered around the U.S. mostly at the actual plants which makes no sense. These people that were let go had an average of 10 years in, many have 20+ years. All that experience out the window. They say they care about their people but they don't. They moved people from France to head up all of the major departments after letting U.S. staff go within the first year of purchasing LF. Also, there was no way to move up while working there. The vibe was pretty bad the last year. New upper management not being transparent so people started to get paranoid.